Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Tyra Biosciences Inc
TYRACurrent price
15.39 USD
-0.98 USD (-5.99%)
Last closed
15.74 USD
Company
www.tyra.bio
ISIN
US90240B1061
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
815 214 336 USD
Yield for 12 month
+30.98 %
1Y
3Y
5Y
10Y
15Y
TYRA
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California. Address: 2656 State Street, Carlsbad, CA, United States, 92008
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
31.67 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-353 000 USD
Last Year
-296 000 USD
Current Quarter
–
Last Quarter
-126 000 USD
Key Figures TYRA
1 year
3 years
5 years
10 years
EBITDA
-99 594 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.21 %
PEG Ratio
–
Return On Equity TTM
-28.66 %
Wall Street Target Price
31.67 USD
Revenue TTM
–
Book Value
6.85 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.61 USD
Diluted Eps TTM
-1.61 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TYRA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TYRA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation TYRA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-6.9506
Price Book MRQ
2.2502
Financials TYRA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TYRA
For 52 weeks
10.6 USD
29.6 USD
50 Day MA
21.86 USD
Shares Short Prior Month
2 381 448
200 Day MA
19.19 USD
Short Ratio
11.33
Shares Short
2 199 375
Short Percent
7.48 %
BeatStart